Predicting Progression in Glaucoma Suspects With Longitudinal Estimates of Retinal Ganglion Cell Counts
dc.contributor.author | Meira-Freitas, Daniel [UNIFESP] | |
dc.contributor.author | Lisboa, Renato [UNIFESP] | |
dc.contributor.author | Tatham, Andrew | |
dc.contributor.author | Zangwill, Linda M. | |
dc.contributor.author | Weinreb, Robert N. | |
dc.contributor.author | Girkin, Christopher A. | |
dc.contributor.author | Liebmann, Jeffrey M. | |
dc.contributor.author | Medeiros, Felipe Andrade [UNIFESP] | |
dc.contributor.institution | Univ Calif San Diego | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Alabama Birmingham | |
dc.contributor.institution | New York Eye & Ear Infirm | |
dc.date.accessioned | 2016-01-24T14:31:49Z | |
dc.date.available | 2016-01-24T14:31:49Z | |
dc.date.issued | 2013-06-01 | |
dc.description.abstract | PURPOSE. We evaluated the ability of baseline and longitudinal estimates of retinal ganglion cell (RGC) counts in predicting progression in eyes suspected of having glaucoma.METHODS. the study included 288 glaucoma suspect eyes of 288 patients followed for an average of 3.8 +/- 1.0 years. Participants had normal standard automated perimetry (SAP) at baseline. Retinal nerve fiber layer thickness assessment was performed with optical coherence tomography (OCT). Progression was defined as development of repeatable abnormal SAP or glaucomatous progressive optic disc changes. Estimates of RGC counts were obtained by combining data from SAP and OCT according to a previously described method. Joint longitudinal survival models were used to evaluate the ability of baseline and rates of change in estimated RGC counts for predicting progression over time, adjusting for confounding variables.RESULTS. A total of 48 eyes (17%) showed progression during follow-up. the mean rate of change in estimated RGC counts was -18,987 cells/y in progressors versus -8,808 cells/y for nonprogressors (P < 0.001). Baseline RGC counts and slopes of RGC loss were significantly predictive of progression, with HRs of 1.56 per 100,000 cells lower (95% confidence interval [CI], 1.18-2.08; P = 0.002) and 2.68 per 10,000 cells/y faster loss (95% CI, 1.22-5.90; P = 0.014), respectively. the longitudinal model including estimates of RGC counts performed significantly better than models including only structural or functional indexes separately.CONCLUSIONS. Baseline and longitudinal estimates of RGC counts may be helpful in predicting progression and performed significantly better than conventional approaches for risk stratification of glaucoma suspects. | en |
dc.description.affiliation | Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA | |
dc.description.affiliation | Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Ophthalmol, São Paulo, Brazil | |
dc.description.affiliation | Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA | |
dc.description.affiliation | New York Eye & Ear Infirm, Dept Ophthalmol, New York, NY 10003 USA | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Ophthalmol, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | National Institutes of Health/National Eye Institute | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | Research to Prevent Blindness (New York, New York) | |
dc.description.sponsorship | Alcon | |
dc.description.sponsorship | Allergan | |
dc.description.sponsorship | Pfizer | |
dc.description.sponsorship | Merck | |
dc.description.sponsorship | Santen | |
dc.description.sponsorshipID | National Institutes of Health/National Eye Institute: EY021818 | |
dc.description.sponsorshipID | National Institutes of Health/National Eye Institute: EY11008 | |
dc.description.sponsorshipID | National Institutes of Health/National Eye Institute: EY14267 | |
dc.description.sponsorshipID | CNPq: 200178/2012-1 | |
dc.format.extent | 4174-4183 | |
dc.identifier | http://dx.doi.org/10.1167/iovs.12-11301 | |
dc.identifier.citation | Investigative Ophthalmology & Visual Science. Rockville: Assoc Research Vision Ophthalmology Inc, v. 54, n. 6, p. 4174-4183, 2013. | |
dc.identifier.doi | 10.1167/iovs.12-11301 | |
dc.identifier.issn | 0146-0404 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/36368 | |
dc.identifier.wos | WOS:000321120700045 | |
dc.language.iso | eng | |
dc.publisher | Assoc Research Vision Ophthalmology Inc | |
dc.relation.ispartof | Investigative Ophthalmology & Visual Science | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | glaucoma | en |
dc.subject | visual field | en |
dc.subject | optical coherence tomography | en |
dc.subject | optic nerve head | en |
dc.subject | intraocular pressure | en |
dc.title | Predicting Progression in Glaucoma Suspects With Longitudinal Estimates of Retinal Ganglion Cell Counts | en |
dc.type | info:eu-repo/semantics/article |